Ticker
CTMXCompany Name
CYTOMX THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 0.93 | $ 119.91M | 1 | 129.08M |
3/31/2025 | $ 0.29 | $ 25.05M | 1 | 87.12M |
12/31/2024 | $ -0.01 | $ -456K | 1 | 84.44M |
9/30/2024 | $ -0.28 | $ -23.45M | 1 | 85.09M |
6/30/2024 | $ -0.37 | $ -31.23M | 1 | 84.88M |
3/31/2024 | $ -0.39 | $ -31.68M | 1 | 82.03M |
12/31/2023 | $ -0.64 | $ -47.45M | 1 | 73.81M |
9/30/2023 | $ -0.63 | $ -51.24M | 1 | 80.73M |
6/30/2023 | $ -1.28 | $ -85.03M | 1 | 66.54M |
3/31/2023 | $ -1.31 | $ -86.64M | 1 | 66.25M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for CYTOMX THERAPEUTICS INC is calculated as follows: Equity [ $ 48.06M ] / (Shares WA [ 46.2M ] * Share Factor [ 1 ])
(=) BVPS [ $ 1.04 ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |